, Volume 49, Issue 1, pp 68–72 | Cite as

The effects of thermogenic agents on hindlimb oxygen consumption in the dog: ICI D7114 and noradrenaline

  • J. L. Gainer
  • M. G. Briscoe
  • B. R. Holloway
Research Articles


The thermogenic action of beta-adrenoceptor agonists may be due, in part, to increased metabolism in skeletal muscle. Previous results suggest that vasoconstriction is also necessary, and that the effect can be blocked by vasodilators. Both noradrenaline and the beta-3 agonist, ICI D7114, were studied using two dog hindlimb protocols. During constant perfusion conditions, ICI D7114 caused a significant increase in hindlimb oxygen consumption although it is a vasodilator. Noradrenaline resulted in a smaller rise in oxygen consumption, and produced a marked vasoconstriction. Both noradrenaline and ICI D7114 resulted in decreased oxygen consumption when the blood flow was allowed to vary in response to the drug treatment. The results suggest that changes in tissue oxygen consumption caused by beta-agonists are not related to vasomotion.

Key words

Beta-adrenoceptor agonist skeletal muscle thermogenic agents oxygen consumption noradrenaline 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Foster, D. O., and Frydman, M. L., Can. J. Physiol. Pharmac.57 (1979) 257.Google Scholar
  2. 2.
    Rothwell, N. J., and Stock, N. J., Nature281 (1979) 31.PubMedGoogle Scholar
  3. 3.
    Colquhoun, E. Q., Hettiarachchi, M., and Clark, M. G., Gen. Pharmac.21 (1990) 141.Google Scholar
  4. 4.
    Jansky, L., in: Nonshivering Thermogenesis, p. 159. Ed. L. Jansky. Academia, Prague 1971.Google Scholar
  5. 5.
    Thomsen, C., Jensen, K. E., Astrup, A., Bülow, J., and Henrikson, O., Acta physiol. scand.137 (1989) 335.PubMedGoogle Scholar
  6. 6.
    Ye, J.-M., Colquhoun, E. Q., Hettiarachchi, M., and Clark, M. G., Can. J. Physiol. Pharmac.68 (1990) 119.Google Scholar
  7. 7.
    Hannon, J. P., Evonuk, E., and Larson, A. M., Fedn Proc.22 (1963) 783.Google Scholar
  8. 8.
    Renkin, E. M., and Rosell, S., Acta physiol. scand.54 (1962) 223.PubMedGoogle Scholar
  9. 9.
    Holloway, B. R., Briscoe, M., Growcott, J. W., Wilson, C., and Stock, M. J., in: Adrenoceptors: Structure, Mechanisms, Functions, p. 313. Birkhäuser Verlag, Basel 1991.Google Scholar
  10. 10.
    Granata, L., Caraffa Braga, E., Cevese, A., and Data, P. G., Pflügers Arch.320 (1970) 64.CrossRefGoogle Scholar
  11. 11.
    Gutierrez, G., Marini, C., Acero, A. L., and Lund, N., J. appl. Physiol.68 (1990) 2047.PubMedGoogle Scholar
  12. 12.
    Mancia, G., Shepherd, J. T., and Donald, D. E., Circ. Res.37 (1975) 200.PubMedGoogle Scholar
  13. 13.
    Bowman, W. C., and Rand, M. S., Textbook of Pharmacology, 2nd edn, p. 5. Blackwell Scientific Publications. Oxford 1980.Google Scholar
  14. 14.
    Horstman, D. H., Gleser, M., and Delehunt, J., Am. J. Physiol.230 (1976) 327.PubMedGoogle Scholar
  15. 15.
    Hogan, M. C., Roca, J., West, J. B., and Wagner, P. D., J. appl. Physiol.66 (1989) 1219.PubMedGoogle Scholar
  16. 16.
    Hogan, M. C., Bebout, D. E., Wagner, P. D., and West, J. B., J. appl. Physiol.69 (1990) 570.PubMedGoogle Scholar
  17. 17.
    Hogan, M. C., Bebout, D. E., and Wagner, P. D., J. appl. Physiol.70 (1990) 1105.Google Scholar

Copyright information

© Birkhäuser Verlag Basel 1993

Authors and Affiliations

  • J. L. Gainer
    • 1
  • M. G. Briscoe
    • 1
  • B. R. Holloway
    • 1
  1. 1.ICI PharmaceuticalsMacclesfield(England)

Personalised recommendations